These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19829307)

  • 1. Negative prognostic impact of PTEN mutation in pediatric T-cell acute lymphoblastic leukemia.
    Jotta PY; Ganazza MA; Silva A; Viana MB; da Silva MJ; Zambaldi LJ; Barata JT; Brandalise SR; Yunes JA
    Leukemia; 2010 Jan; 24(1):239-42. PubMed ID: 19829307
    [No Abstract]   [Full Text] [Related]  

  • 2. The significance of PTEN and AKT aberrations in pediatric T-cell acute lymphoblastic leukemia.
    Zuurbier L; Petricoin EF; Vuerhard MJ; Calvert V; Kooi C; Buijs-Gladdines JG; Smits WK; Sonneveld E; Veerman AJ; Kamps WA; Horstmann M; Pieters R; Meijerink JP
    Haematologica; 2012 Sep; 97(9):1405-13. PubMed ID: 22491738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward a NOTCH1/FBXW7/RAS/PTEN-based oncogenetic risk classification of adult T-cell acute lymphoblastic leukemia: a Group for Research in Adult Acute Lymphoblastic Leukemia study.
    Trinquand A; Tanguy-Schmidt A; Ben Abdelali R; Lambert J; Beldjord K; Lengliné E; De Gunzburg N; Payet-Bornet D; Lhermitte L; Mossafa H; Lhéritier V; Bond J; Huguet F; Buzyn A; Leguay T; Cahn JY; Thomas X; Chalandon Y; Delannoy A; Bonmati C; Maury S; Nadel B; Macintyre E; Ifrah N; Dombret H; Asnafi V
    J Clin Oncol; 2013 Dec; 31(34):4333-42. PubMed ID: 24166518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of PTEN, PI3K, and AKT abnormalities in T-cell acute lymphoblastic leukemia.
    Gutierrez A; Sanda T; Grebliunaite R; Carracedo A; Salmena L; Ahn Y; Dahlberg S; Neuberg D; Moreau LA; Winter SS; Larson R; Zhang J; Protopopov A; Chin L; Pandolfi PP; Silverman LB; Hunger SP; Sallan SE; Look AT
    Blood; 2009 Jul; 114(3):647-50. PubMed ID: 19458356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic PTEN functions and models in T-cell malignancies.
    Tesio M; Trinquand A; Macintyre E; Asnafi V
    Oncogene; 2016 Jul; 35(30):3887-96. PubMed ID: 26616857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell profiling of pediatric T-cell acute lymphoblastic leukemia: Impact of PTEN exon 7 mutation on PI3K/Akt and JAK-STAT signaling pathways.
    Bonaccorso P; Bugarin C; Buracchi C; Fazio G; Biondi A; Lo Nigro L; Gaipa G
    Cytometry B Clin Cytom; 2020 Nov; 98(6):491-503. PubMed ID: 32479694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related clinical and biological features of PTEN abnormalities in T-cell acute lymphoblastic leukaemia.
    Tesio M; Trinquand A; Ballerini P; Hypolite G; Lhermitte L; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Asnafi V
    Leukemia; 2017 Dec; 31(12):2594-2600. PubMed ID: 28539671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of STIL/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
    Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
    Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOTCH1 activation clinically antagonizes the unfavorable effect of PTEN inactivation in BFM-treated children with precursor T-cell acute lymphoblastic leukemia.
    Bandapalli OR; Zimmermann M; Kox C; Stanulla M; Schrappe M; Ludwig WD; Koehler R; Muckenthaler MU; Kulozik AE
    Haematologica; 2013 Jun; 98(6):928-36. PubMed ID: 23349303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN/PI3K/Akt pathway alters sensitivity of T-cell acute lymphoblastic leukemia to L-asparaginase.
    Hlozkova K; Hermanova I; Safrhansova L; Alquezar-Artieda N; Kuzilkova D; Vavrova A; Sperkova K; Zaliova M; Stary J; Trka J; Starkova J
    Sci Rep; 2022 Mar; 12(1):4043. PubMed ID: 35260738
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Küçükcankurt F; Erbilgin Y; Fırtına S; Hatırnaz Ng Ö; Karakaş Z; Celkan T; Ünüvar A; Özbek U; Sayitoğlu M
    Turk J Haematol; 2020 May; 37(2):98-103. PubMed ID: 31744268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focused chemical genomics using zebrafish xenotransplantation as a pre-clinical therapeutic platform for T-cell acute lymphoblastic leukemia.
    Bentley VL; Veinotte CJ; Corkery DP; Pinder JB; LeBlanc MA; Bedard K; Weng AP; Berman JN; Dellaire G
    Haematologica; 2015 Jan; 100(1):70-6. PubMed ID: 25281505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTEN microdeletions in T-cell acute lymphoblastic leukemia are caused by illegitimate RAG-mediated recombination events.
    Mendes RD; Sarmento LM; Canté-Barrett K; Zuurbier L; Buijs-Gladdines JG; Póvoa V; Smits WK; Abecasis M; Yunes JA; Sonneveld E; Horstmann MA; Pieters R; Barata JT; Meijerink JP
    Blood; 2014 Jul; 124(4):567-78. PubMed ID: 24904117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of PTEN abnormalities on outcome in pediatric patients with T-cell acute lymphoblastic leukemia treated on the MRC UKALL2003 trial.
    Jenkinson S; Kirkwood AA; Goulden N; Vora A; Linch DC; Gale RE
    Leukemia; 2016 Jan; 30(1):39-47. PubMed ID: 26220040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of amino acid transport coordinates metabolic reprogramming in T-cell malignancy.
    Grzes KM; Swamy M; Hukelmann JL; Emslie E; Sinclair LV; Cantrell DA
    Leukemia; 2017 Dec; 31(12):2771-2779. PubMed ID: 28546582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of the absence of biallelic deletion at the
    Farah N; Kirkwood AA; Rahman S; Leon T; Jenkinson S; Gale RE; Patrick K; Hancock J; Samarasinghe S; Linch DC; Moorman AV; Goulden N; Vora A; Mansour MR
    Haematologica; 2018 Jul; 103(7):e288-e292. PubMed ID: 29519867
    [No Abstract]   [Full Text] [Related]  

  • 17. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells.
    Zhou M; Gu L; Findley HW; Jiang R; Woods WG
    Cancer Res; 2003 Oct; 63(19):6357-62. PubMed ID: 14559824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic Value of Recurrent Molecular Genetics and Epigenetics Abnormity in T Lymphoblastic Lymphoma / Leukemia -Review].
    Guan W; Jing Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):587-591. PubMed ID: 28446316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic basis of pediatric T-cell acute lymphoblastic leukemia and its clinical impact].
    Takita J
    Rinsho Ketsueki; 2018; 59(7):953-959. PubMed ID: 30078808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mission impossible: IGF-1 and PTEN specifically "Akt"ing on cardiac L-type Ca2+ channels.
    Kamp TJ; Chiamvimonvat N
    Circ Res; 2006 Jun; 98(11):1349-51. PubMed ID: 16763171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.